Researchers at the Massachusetts Institute of Technology (MIT) have created Boltz-1, an open-source artificial intelligence model designed to accelerate biomedical research and drug development. Boltz-1 competes with Google’s AlphaFold3 and aims to democratize access to cutting-edge tools in structural biology,…

India faces a significant challenge from antibiotic resistance, with over 300,000 deaths annually linked to resistant infections. Researchers are developing new drugs such as Enmetazobactam, which has received FDA approval, and Zaynich, currently in Phase 3 trials. Experts call for…